Provided by Tiger Fintech (Singapore) Pte. Ltd.

SeaStar Medical Holding Corporation

1.27
+0.07806.54%
Pre-market: 1.290.0217+1.71%08:58 EDT
Volume:149.55K
Turnover:183.21K
Market Cap:13.42M
PE:-0.19
High:1.27
Open:1.20
Low:1.18
Close:1.19
Loading ...

Top Executive Sells Shares in ICU Medical!

TIPRANKS
·
31 May

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients With Cardiorenal Syndrome Awaiting Lvad in Investigational Trial of Scd Therapy

THOMSON REUTERS
·
28 May

Director Jennifer A. Baird Reports Acquisition of Common Shares in Seastar Medical Holding Corporation

Reuters
·
23 May

Director Cashes In on ICU Medical Stock Sale!

TIPRANKS
·
21 May

Kevin Chung, Chief Medical Officer, Reports Acquisition of Common Shares in Seastar Medical Holding Corporation

Reuters
·
21 May

ICU Medical’s COO Makes a Bold Move with Stock Sale

TIPRANKS
·
20 May

SeaStar Medical files to sell 4.74M shares of common stock for holders

TIPRANKS
·
20 May

SeaStar Medical Holding Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

SeaStar Medical Holding Q1 EPS $(0.44) Beats $(0.52) Estimate, Sales $293.00K Beat $150.00K Estimate

Benzinga
·
15 May

SeaStar Medical Reaches Interim Enrollment Target for Neutralize-Aki Pivotal Trial of Scd Therapy for Adult Patients With Acute Kidney Injury

THOMSON REUTERS
·
13 May

SeaStar Medical Holding Corp expected to post a loss of 52 cents a share - Earnings Preview

Reuters
·
13 May

ICU Medical Balances Growth and Challenges in Earnings Call

TIPRANKS
·
10 May

ICU Medical Is Maintained at Strong Buy by Raymond James

Dow Jones
·
10 May

SeaStar Medical Holding Corp expected to post a loss of 52 cents a share - Earnings Preview

Reuters
·
09 May

ICU Medical Q1 Adjusted Earnings, Revenue Increase

MT Newswires Live
·
09 May

Malaysian footballer acid attack: ‘No further action’ from public prosecutor but police will continue probe

CNA
·
09 May

ICU Medical Q1 Adj. EPS $1.72 Beats $1.28 Estimate, Sales $604.70M Beat $570.12M Estimate

Benzinga
·
09 May

ICU Medical, Otsuka Pharmaceutical Factory Form IV Joint Venture

MT Newswires Live
·
01 May

ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America

PR Newswire
·
01 May

BRIEF-Seastar Medical Announces CEO Interview On Benzinga

Reuters
·
30 Apr